Gene · 64005
NIH grants1,131
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,131
Download this page as JSON| Grant | Title | MYO1G papers | Newest fiscal year |
|---|---|---|---|
| R01AI125524 | Kinase Regulation of Nuclear Speckle Function and Splicing during Influenza Virus Infection | 1 | 2025 |
| R01AI125534 | Determinants of apicoplast maintenance in malaria parasites | 1 | 2025 |
| R01AI132413 | Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections | 1 | 2025 |
| R01AI165644 | Impact of intra-host population structure on influenza virus antigenic evolution | 1 | 2025 |
| R01AI169619 | Flipped Germinal Centers | 1 | 2025 |
| R01AI170715 | Antibody Durability Dynamics | 1 | 2025 |
| R01AR055685 | Probing the activity of DUX4 in FSHD | 1 | 2025 |
| R01AR077992 | Informing Osteoporosis GWAS Using Networks | 1 | 2025 |
| R01CA114536 | Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy | 1 | 2025 |
| R01CA178441 | Combinatorial epigenetic-based prevention of breast cancer | 1 | 2025 |
| R01CA186702 | Mechanisms of epitranscriptomic regulation in cancer | 1 | 2025 |
| R01CA205420 | Enhancing miRNA Therapeutics through Vehicle Free Delivery | 1 | 2025 |
| R01CA226259 | Ligand-mediated, vehicle-free delivery of small RNAs | 1 | 2025 |
| R01CA265726 | Selective pressures from inherited variation impacting myeloproliferative neoplasm initiation | 1 | 2025 |
| R01CA276683 | Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer | 1 | 2025 |
| R01DC003594 | Identification of Autosomal Recessive Nonsyndromic Hearing Impairment Genes | 1 | 2025 |
| R01DC008983 | Contribution of striatum to central auditory processing | 1 | 2025 |
| R01DC015997 | Barriers and facilitators to over-the-counter hearing aids success: A patient journey approach | 1 | 2025 |
| R01DK103794 | Systematic Genetic Dissection of Human Erythropoiesis | 1 | 2025 |
| R01ES028271 | Investigation of human DNA polymerase epsilon variants | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64005/grants?page=6